Research Roundup

Debbie Rigby takes a look at the latest in research news Medication-related osteonecrosis of the jaw Analysis of the Australian database of adverse event notifications identified medications reported to cause osteonecrosis of the jaw, including adalimumab, etanercept, methotrexate and rituximab. The majority of reported cases occurred with bisphosphonates and denosumab. The most common trigger for

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous AJP chats with… Verity Boustead
Next $12 billion saving if all qualified pharmacists can COVID vaccinate